Application of recombinant thioredoxin1 for treatment of heart disease

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 4, 2011, Pages 570-573

  Matsushima, Shouji ^a   Zablocki, Daniela ^a   Sadoshima, Junichi ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Disulfide bond; Ischemia reperfusion; Pathological cardiac hypertrophy; Recombinant; Small molecule; Thioredoxin1

Indexed keywords

CYSTEINE; DISULFIDE; RECOMBINANT PROTEIN; RECOMBINANT THIOREDOXIN 1; TEPRENONE; THIOL; THIOREDOXIN 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; CARDITIS; CHEMICAL REACTION; DISULFIDE BOND; DRUG MECHANISM; EXTRACELLULAR SPACE; GENE CONTROL; HEART DISEASE; HEART HYPERTROPHY; HEART INJURY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; INTRACELLULAR SPACE; ISCHEMIC PRECONDITIONING; MITOCHONDRIAL GENE; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; UPREGULATION;

ANIMALS; CARDIOMEGALY; HEART; HEART DISEASES; HUMANS; MYOCARDIAL REPERFUSION INJURY; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; THIOREDOXINS;

EID: 80052810762     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.09.020     Document Type: Review

References (21)

1. Yellon D.M., Hausenloy D.J. Myocardial reperfusion injury. N Engl J Med 2007, 357:1121-1135.
2. Nakamura H., Hoshino Y., Okuyama H., Matsuo Y., Yodoi J. Thioredoxin 1 delivery as new therapeutics. Adv Drug Deliv Rev 2009, 61:303-309.
3. Ago T., Sadoshima J. Thioredoxin and ventricular remodeling. J Mol Cell Cardiol 2006, 41:762-773.
4. Turoczi T., Chang V.W., Engelman R.M., Maulik N., Ho Y.S., Das D.K. Thioredoxin redox signaling in the ischemic heart: an insight with transgenic mice overexpressing Trx1. J Mol Cell Cardiol 2003, 35:695-704.
5. Yamamoto M., Yang G., Hong C., Liu J., Holle E., Yu X., et al. Inhibition of thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest 2003, 112:1395-1406.
6. Samuel S.M., Thirunavukkarasu M., Penumathsa S.V., Koneru S., Zhan L., Maulik G., et al. Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic rats. Circulation 2010, 121:1244-1255.
7. Tao L., Gao E., Bryan N.S., Qu Y., Liu H.R., Hu A., et al. Cardioprotective effects of thioredoxin in myocardial ischemia and reperfusion: role of S-nitrosation [corrected]. Proc Natl Acad Sci USA 2004, 101:11471-11476.
8. Das D.K. Thioredoxin regulation of ischemic preconditioning. Antioxid Redox Signal 2004, 6:405-412.
9. Fu C., Hu J., Ago T., Sadoshima J., Li H. Quantitative analysis of redox-sensitive proteome with DIGE and ICAT. J Proteome Res 2008, 7:3789-3802.
10. Ago T., Yeh I., Yamamoto M., Schinke-Braun M., Brown J.A., Tian B., et al. Thioredoxin1 upregulates mitochondrial proteins related to oxidative phosphorylation and TCA cycle in the heart. Antioxid Redox Signal 2006, 8:1635-1650.
11. Bai J., Nakamura H., Hattori I., Tanito M., Yodoi J. Thioredoxin suppresses 1-methyl-4-phenylpyridinium-induced neurotoxicity in rat PC12 cells. Neurosci Lett 2002, 321:81-84.
12. Li X., Tang K., Xie B., Li S., Rozanski G.J. Regulation of Kv4 channel expression in failing rat heart by the thioredoxin system. Am J Physiol Heart Circ Physiol 2008, 295:H416-H424.
13. Kaga S., Zhan L., Matsumoto M., Maulik N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 2005, 39:813-822.
14. Backs J., Olson E.N. Control of cardiac growth by histone acetylation/deacetylation. Circ Res 2006, 98:15-24.
15. Erickson J.R., Joiner M.L., Guan X., Kutschke W., Yang J., Oddis C.V., et al. A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 2008, 133:462-474.
16. Ago T., Liu T., Zhai P., Chen W., Li H., Molkentin J.D., et al. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 2008, 133:978-993.
17. Nott A., Watson P.M., Robinson J.D., Crepaldi L., Riccio A. S-nitrosylation of histone deacetylase 2 induces chromatin remodelling in neurons. Nature 2008, 455:411-415.
18. Ago T., Sadoshima J. Thioredoxin1 as a negative regulator of cardiac hypertrophy. Antioxid Redox Signal 2007, 9:679-687.
19. Kondo N., Ishii Y., Kwon Y.W., Tanito M., Sakakura-Nishiyama J., Mochizuki M., et al. Lipid raft-mediated uptake of cysteine-modified thioredoxin-1: apoptosis enhancement by inhibiting the endogenous thioredoxin-1. Antioxid Redox Signal 2007, 9:1439-1448.
20. Wu C., Liu T., Chen W., Oka S., Fu C., Jain M.R., et al. Redox regulatory mechanism of transnitrosylation by thioredoxin. Mol Cell Proteomics 2010, 9(10):2262-2275. [Epub 2010 Jul21].
21. Benhar M., Forrester M.T., Hess D.T., Stamler J.S. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.